Form 4: Inhibrx Biosciences Director Sells Shares
Insider Transaction (Form 4)
Kimberly Manhard, a Director of Inhibrx Biosciences, Inc., sold 1,500 shares of common stock on September 11, 2026.
Summary
- Open-market sale: disposed of 500 Common Stock at $111.78 ($55,888) on September 11, 2026; holds 8,500 after (Indirect).
- Open-market sale: disposed of 500 Common Stock at $110.26 ($55,130) on September 14, 2026; holds 8,000 after (Indirect).
- Open-market sale: disposed of 500 Common Stock at $105.05 ($52,525) on September 15, 2026; holds 7,500 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $163,542 of stock on the open market.
Insider Transactions
Kimberly Manhard — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-11 | Open-market sale | Common Stock | 500 | $112 | $55.9K | 8,500 |
| 2026-09-14 | Open-market sale | Common Stock | 500 | $110 | $55.1K | 8,000 |
| 2026-09-15 | Open-market sale | Common Stock | 500 | $105 | $52.5K | 7,500 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-11 | Open-market sale (500 shares) |
| 2026-09-14 | Open-market sale (500 shares) |
| 2026-09-15 | Open-market sale (500 shares) |
Keywords
insider transaction, Form 4, INBX, Inhibrx Biosciences, Inc., bearish, Kimberly Manhard
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.